New analgesic-anti-inflammatory drugs. 1-Oxo-2-substituted isoindoline derivatives.
D000700:Analgesics / Q000138:chemical synthesis* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002351:Carrageenan; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D007211:Indoles / Q000138:chemical synthesis* / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D007211:Indoles; D002351:Carrageenan; D010653:Phenylbutazone; D007213:Indomethacin